Pancreatic Cancer

Report Evaluates Emerging Therapies

Published in Vaccine Weekly, February 20th, 2002

Decision Resources, Inc., announces the publication of "Pancreatic Cancer," a new study that evaluates the current status of, and future prospects for, therapies to treat this highly virulent cancer.

Pancreatic cancer (PC) is a biologically complex disease that is highly resistant to treatment. For more than 80% of patients with pancreatic cancer, no effective treatment exists, and few patients with advanced stage disease are alive after one year. Therefore, any well-tolerated, efficacious therapy would encounter few obstacles on its way to market penetration.

Experts contacted by Decision Resources consider therapeutic vaccines and epidermal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-02-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry